Skip to main content

Safety Alerts

By
VIROLOGICAL FAILURE IN HIV PATIENTS TREATED WITH THE COMBINATION OF DIDANOSINE, LAMIVUDINE AND TENOFOVIR
The World Health Organisation (WHO) in collaboration with the European Medical Evaluation Agency (EMEA), have issued a public statement warning about the high rate of Virologic failure in HIV patients treated with a triple nucleoside/nucleotide reverse transcriptase inhibitors combination containing Didanosine, Lamivudine and Tenofovir.
The warning statement is based on the observation of a high rate of virologic failure in a clinical study of HIV-infected patients receiving a once-day triple combination containing tenofovir (Viread, TDF), lamivudine (Epivir, 3TC) and enteric coated bedlets (Videx EC, ddI EC)
In the meantime doctors are advised as precautionary measure, NOT to use Tenofovir in combination with Didanosine and Lamivudine  when considering a new treatment regimen for therapy or treatment experienced HIV patients.
Patients already on therapy with above combination should be frequently monitored with a viral load test and considered for modification of therapy at first sign of viral load increase.
The precise nature of any interaction leading to non-response is currently unknown and is being investigated.
For further information contact TFDA
COUNTERFEIT TRIPLE ARV COMBINATION PRODUCT (GINOVIR 3D)
The Tanzania Food and Drugs Authority (TFDA) has received a warning information from the World Health Organisation (WHO) on the presence of counterfeit triple antiretroviral combination product, Ginovir 3D capsules, in Cote d’Ivoire.
The label of the medicines showed that each capsule of Ginovir 3D contained Zidovudine (200 mg), Lamivudine (150 mg) and Indinavir (40 mg). Laboratory tests however, did not show the presence of Lamivudine or Indinavir; the capsules were found to contain 201 mg of Zidovudine and 40 mg of Stavudine in addition to a non-identified substance. Labels indicated that the products were manufactured by Selchi Pharmaceuticals, P. O. Box 3351, WINDHOEK, Namibia.
TFDA would like to pass this warning statement to health care providers and the public in general as precautionary measure to stay alert to the possible presence of this product in our market.
Please communicate with TFDA once you see a similar product.

Comments

Post a Comment

Popular posts from this blog

carrier path event on 17th june 2015

By
prof KENNEDY MWAMBETE   Ms.   E l izabeth   Shekala g he,   R e gis t rar pharmacy council  giving speech through Skype  front seat PROF KAALE{LEFT} ,SILO, Mr GEORGE,Issa, Mr   A nant   Bhalani   Mr.   George   Lugat a ,   T er r i t or y   manager   T i g o  Students and other stuff members listening to speeches  dean School of Pharmacy Prof Veronica Mgoyela CHAIR MAN SCHOOL OF PHARMACY PIUS DANIEL KIWANGO {Wth neck tie} PROF KAALE   Discussions/Que s tions   a nd   Answers   Mr.   H i i t i   S il o ,   D G   TFDA  responding to questions from students  Tumain Makole asking question  Jesse bpharm4 aking questions
Post a Comment
Read more

NATIONAL PHARMACY WEEK 14th-20th JUNE 2015

By
PHARMACEUTICAL ASSOCCIATION OF TANZANIA NATIONAL PHARMACY WEEK 14 TH - 20 TH JUNE 2015 Theme Self-medication: How safe? Ask your Pharmacist PROGRAM FOR TAPSA PARTICIPATION 19 TH at MLIMANI CITY, MAKUMBUSHO AND KIVUKONI 20 TH at MNAZI MMOJA Come to our tents and get free advice FREE TRANSPORT, MEALS AND DRINKS WILL BE PROVIDED DON’T DARE TO MISS IT Self-medication self-medication is defined as "the use of drugs to treat self-diagnosed disorders or symptoms, or the intermittent or continued use of a prescribed drug for chronic or recurrent disease or symptom Or is a human behavior in which an individual uses a substance or any exogenous influence to self-administer treatment for non-clinical physical or psychological ailments.
Post a Comment
Read more

ABOUT TAPSA

By
Being the student aspiring to be health cadre delivers and service providers we are entitled responsibility to the Tanzanians and world at large as tomorrow health practitioners. Having a goal to prepare diligent health professionals ADUPS was founded in Mid August 1987 by MUCHS pharmacy students and as a result of guidance and support from IPSF, the association was officially registered on the 4th April 1990 in UDSM.  It became a full member of IPSF and APSF in August 1993 and September 2002 respectively.  ADUPS has being active for almost twenty years and her members have every reason to be proud for attaining this age. In the year-2007 MUCHS declared transformation from being a constituent College of University of Dar es Salaam to full fledged University hereby namely MUHAS. ADUPS had to transform her name and become TAPSA.  Following this expansion the association is having chapters in Colleges/Universities providing a bachelor of P...
2 comments
Read more